Skip to main content

Table 1 Demographics of participants with NGJH (Non Generalised Joint Hypermobility), GJH (Generalised Joint Hypermobility) and GJHS (GJH including shoulder joint hypermobility)

From: Generalised joint hypermobility and shoulder joint hypermobility, – risk of upper body musculoskeletal symptoms and reduced quality of life in the general population

Variable All
(n = 989)
NGJH
(n = 689)
GJH
(n = 300)
p-value GJHS
(n = 51)
p-value
Women, % (no.) 55.9 (553) 47.3 (326) 75.7 (227) <0.001* 76.5 (39) <0.001*
Age, median (IQR) 50 (40–57) 50 (41–57) 48 (38–55.5) 0.025 46 (34–57) 0.145
BMI (Kg/m2), median (IQR) 25.4 (22.9–28.1) 25.5 (23.1–28.1) 25.1 (22.5–28.1) 0.151 24.5 (21.2–29.0) 0.284
Work-related status, % (no.)     0.188   0.149
 Employed 71.2 (704) 72.3 (498) 68.7 (206)   54.9 (28)  
 Un-employed 3.74 (37) 3.34 (23) 4.67 (14)   3.92 (2)  
 Student 3.74 (37) 3.19 (22) 5.00 (15)   5.88 (3)  
 Absent because of illness 1.82 (18) 1.60 (11) 2.33 (7)   3.92 (2)  
 Early retired 3.94 (39) 3.19 (22) 5.67 (17)   7.84 (4)  
 Retired 4.15 (41) 4.06 (28) 4.33 (13)   7.84 (4)  
 Other 11.43 (113) 12.3 (85) 9.33 (28)   15.7 (8)  
EuroQol VAS, median (IQR) 85 (75–90) 85 (75–90) 80 (70–90) <0.001* 75 (60–90) <0.001*
EQ-5D Index, median (IQR) 0.86 (0.77–1) 0.86 (0.78–1) 0.82 (0.74–0.86) <0.001* 0.79 (0.67–0.86) <0.001*
  1. *Indicates a statistical significant difference (p-value <0.025) between participants with NGJH and GJH, and between NGJH and GJHS